Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Multiple sclerosis

CCSVI deconstructed and discarded

Chronic cerebrospinal venous insufficiency (CCSVI) has been proposed as a cause of multiple sclerosis (MS). However, two new studies found a very low overall prevalence of definite CCSVI, and no association with MS. The data confirm that the ultrasound findings of CCSVI are extremely variable, subjective, and based on major methodological flaws.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Case of a 27-year-old woman with relapsing–remitting multiple sclerosis.

References

  1. Zamboni, P. et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 80, 392–399 (2009).

    Article  CAS  Google Scholar 

  2. Zamboni, P. et al. The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis. J. Neurol. Sci. 282, 21–27 (2009).

    Article  Google Scholar 

  3. Valdueza, J. M. et al. What went wrong? The flawed concept of cerebrospinal insufficiency. J. Cereb. Blood Flow Metab. 33, 657–668 (2013).

    Article  Google Scholar 

  4. Comi, G. et al. Observational case–control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study. Mult. Scler. 19, 1508–1517 (2013).

    Article  CAS  Google Scholar 

  5. Traboulsee, A. L. et al. Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case–control study. Lancet http://dx.doi.org/10.1016/S0140–6736(13)61747-X.

  6. Wattjes, M. P., Doepp, F., Bendszus, M. & Fiehler, J. “Chronic cerebrospinal venous insufficiency” in multiple sclerosis—is multiple sclerosis a disease of the cerebrospinal venous outflow system? [German] Rofo 183, 523–530 (2011).

    Article  CAS  Google Scholar 

  7. Khan, O. et al. Chronic cerebrospinal venous insufficiency and multiple sclerosis. Ann. Neurol. 67, 286–290 (2010).

    Article  Google Scholar 

  8. Reekers, J. A., Lee, M. J., Belli, A. M., Barkhof, F. Cardiovascular and Interventional Radiological Society of Europe commentary on the treatment of chronic cerebrospinal venous insufficiency. Cardiovasc. Intervent. Radiol. 34, 1–2 (2011).

    Article  CAS  Google Scholar 

  9. The truth about the COSMO study. Facebook[online], (2013).

  10. Chronic cerebrospinal venous insufficiency (CCSVI). MS Society[online], (2013).

Download references

Acknowledgements

The authors thank Jim Reekers and Bob van Oosten for their comments and the multiple sclerosis patient for the permission to reproduce her MRI scan in Figure 1.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frederik Barkhof.

Ethics declarations

Competing interests

F. Barkhof has received consultancy fees from Bayer-Schering, Roche, Merck Serono, Genzyme, Teva, Biogen Idec and Novartis for serving on steering committees, advisory boards and data-safety monitoring committees. M. P. Wattjes has received speaker honoraria from Bayer Healthcare, Janssen-Cilag, Novartis and Biogen Idec.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barkhof, F., Wattjes, M. CCSVI deconstructed and discarded. Nat Rev Neurol 9, 661–662 (2013). https://doi.org/10.1038/nrneurol.2013.228

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2013.228

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing